Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Maertens

Showing results (61-70 of 418) with videos related to

Pageof 42
Sort By:
BMC Infectious Diseases|December 12, 2024
Correction: Review of the novel antifungal drug olorofim (F901318)Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, et al.
BMC Infectious Diseases|November 7, 2024
Review of the novel antifungal drug olorofim (F901318)Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, et al.
Mycoses|July 18, 2019
Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosisToine Mercier, Agustin Reséndiz Sharpe, Dieter Waumans, et al.
Haematologica|February 2, 2011
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipientsCatherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2009
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitisIsabel Spriet, Lien Delaere, Katrien Lagrou, et al.
The Journal of Infectious Diseases|October 29, 2002
Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipientsJohan Maertens, Johan Van Eldere, Jan Verhaegen, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous modelSona Kucharíková, Nidhi Sharma, Isabel Spriet, et al.
European Journal of Medical Research|April 19, 2012
Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registryGerlinde Egerer, Dietmar Reichert, Mathias W Pletz, et al.
Emerging Infectious Diseases|April 23, 2014
Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013Tom Eyckmans, Elke Wollants, Ann Janssens, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2024
Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debateJohan Maertens, Monica Slavin, Martin Hoenigl, et al.
Pageof 42

Showing results (61-70 of 418) with videos related to

Sort By:
Pageof 42
BMC Infectious Diseases|December 12, 2024
Correction: Review of the novel antifungal drug olorofim (F901318)Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, et al.
BMC Infectious Diseases|November 7, 2024
Review of the novel antifungal drug olorofim (F901318)Yuri Vanbiervliet, Tine Van Nieuwenhuyse, Robina Aerts, et al.
Mycoses|July 18, 2019
Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosisToine Mercier, Agustin Reséndiz Sharpe, Dieter Waumans, et al.
Haematologica|February 2, 2011
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipientsCatherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
The Journal of Antimicrobial Chemotherapy|August 18, 2009
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitisIsabel Spriet, Lien Delaere, Katrien Lagrou, et al.
The Journal of Infectious Diseases|October 29, 2002
Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipientsJohan Maertens, Johan Van Eldere, Jan Verhaegen, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous modelSona Kucharíková, Nidhi Sharma, Isabel Spriet, et al.
European Journal of Medical Research|April 19, 2012
Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registryGerlinde Egerer, Dietmar Reichert, Mathias W Pletz, et al.
Emerging Infectious Diseases|April 23, 2014
Coxsackievirus A16 encephalitis during obinutuzumab therapy, Belgium, 2013Tom Eyckmans, Elke Wollants, Ann Janssens, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2024
Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debateJohan Maertens, Monica Slavin, Martin Hoenigl, et al.
Pageof 42